We report on three cases of visual loss due to nonarteritic anterior ischemic optic neuropathy that developed during the course of refractory anemia, a subtype of myelodysplastic syndrome. Patients and methods: Patients underwent fundus, visual fi eld examination, and fl uorescein angiography. A thrombophilic tendency investigation including prothrombin time, partial thromboplastin time, protein C, free protein S, and antithrombin III, polymerase chain reaction and hybridisation to allele-specifi c oligonucleotide probes and a bone marrow biopsy were also performed. Results: Relative recovery of visual function was noted in two patients, a 58-year-old man and a 67-year-old woman, whereas the vision of the third patient, a 62-year-old man, showed only marginal improvement during the follow-up period. Two patients received vigorous blood transfusion during hospitalization, while dosage adjustment of the erythropoietin infusion was decided for the third one. Thrombophilic tendency was not identifi ed in any patient. Discussion: Chronic anemia, as presented in myelodysplastic syndrome's refractory anemia subtype, probably in the presence of additional factors, such as hypotension, is likely to be complicated by optic neuropathy, possibly through a mechanism of anemic hypoxia and/or microvascular insuffi ciency.
Introduction
Nonarteritic ischemic optic neuropathy (NAION) typically occurs as a unilateral process in older patients who have vasculopathic risk factors, 1 with rapid onset, stable course and generally poor recovery. The most commonly proposed pathogenic theory involves an insuffi ciency of the optic disc circulation, exacerbated by structural "crowding" of nerve fi bers and supporting structures at the nerve head, resulting in inadequate oxygenation, ischemia and swelling of the disc. An altitudinal fi eld defect, usually involving the inferior fi eld, is most common, but generalized depression, broad arcuate scotomas, and cecocentral defects also are seen. 2 The myelodysplastic syndromes (MDS) are a heterogeneous group of stem cell malignancies characterized by dysplastic and ineffective blood cell production and a variable risk of transformation to acute leukaemia. 3 We report on three cases of nonarteritic anterior ischemic optic neuropathy (NAION), which developed during the course of refractory anemia, one of the morphological subtypes of MDS. 4 
Case reports Case 1
A 58-year-old man presented with left-sided painless blurring of vision of one-week duration. His medical and ophthalmic history was unremarkable but he complained of moderate malaise and fatigue of recent onset. Best-corrected visual acuity was 20/50 OD and 20/150 OS. Mild nuclear cataract was noted bilaterally. A relative afferent pupillary defect was present in the left eye. Fundus examination revealed sectorial optic disc edema in the left eye, which corresponded to optic disc fi lling delay and late leakage on fl uorescein angiography (Figure 1 ) as well as a related broad inferior-nasal arcuate scotoma. The erythrocyte sedimentation rate was 20 mm (1st hour) and C-reactive protein was within normal range. A full blood count showed profound anemia (hemoglobin 55 g/l), and moderate leucopenia (4.9 × 10 9 /lt) and thrombocytopenia (114 × 10 9 /lt). Blood pressure was 90/65 mmHg, pulse 105/min. A carotid Doppler study was normal. Further investigation in search of a thrombophilic tendency, including prothrombin time, partial thromboplastin time, protein C, free protein S, and antithrombin III yielded normal values. Polymerase chain reaction and hybridisation to allele-specific oligonucleotide probes (ViennaLab Labordiagnostika GmbH, Vienna, Austria) did not identify prothrombin, factor V or MTHFR thrombophilic mutations.
A diagnosis of anterior ischemic optic neuropathy was made and the patient was referred to the Internal Medicine Department for further evaluation. A bone marrow biopsy was suggestive of myelodysplasia (subtype refractory anemia). 4 Transfusions of packed red cells, initiated two weeks following the approximate date of initiation of symptoms, raised hemoglobin to 98 g/l, and were followed by biweekly transfusions and initiation of erythropoietin in order to maintain hemoglobin over 100 g/l.
Within 10 days following admission, the visual acuity of the left eye had improved to 20/50 and remained stable for the rest of a six-month follow-up period, during which sectorial left optic disc pallor ensued.
Case 2
A 67-year-old woman presented with a fi ve-day history of painless visual impairment in the left eye. Her medical history included chronic renal failure of unknown etiology controlled with hemodialysis, hypothyroidism and myelodysplastic syndrome (classifi ed as refractory anemia) 4 diagnosed three months earlier. The patient was on thyroid hormone substitution therapy but erythropoietin was not prescribed, as an earlier attempt had resulted in the thrombotic occlusion of her arteriovenous fi stula. On admission, the best-corrected visual acuity was 20/50 OD and 20/800 OS. A left-sided relative afferent pupillary defect was present. Apart from bilateral mild senile cataract, anterior segment examination was unremarkable. Funduscopy and fl uorescein angiography revealed an optic nerve head edema in the left eye, corresponding to visual fi eld generalized depression.
Erythrocyte sedimentation rate was 17 mm (1st hour). C-reactive protein was found within normal range. On initial work-up, hemoglobin was 79 g/l, white blood cell count 11.3 × 10 9 /lt and platelets 307 × 10 9 /lt. Transfusion of packed red cells was initiated on the second day of admission in order to increase hemoglobin levels. Blood pressure was within normal range throughout hospitalization. Carotid bruits were not noted and a Doppler study showed normal carotid blood fl ow.
Within one week of hospitalization, visual acuity improved to 20/60 OS and remained stable for the rest of the follow-up period (6 months). During this period visual fi elds also improved and pallor of the left optic disc was noted.
Case 3
A 62-year-old man presented with painless reduction of visual acuity in the left eye that developed during the course of a lower respiratory tract infection a few days earlier.
His medical history included myelodysplastic syndrome (classifi ed as refractory anemia) 4 diagnosed three years earlier, in the course of the laboratory investigation for chronic malaise and fatigue. The patient was put on an erythropoietin regimen that had increased his pre-treatment hematocrit from 27% to 34.5%. On admission, the best-corrected visual acuity was 20/50 OD and 20/400 OS. A left-sided relative afferent pupillary defect was present and, apart from bilateral mild senile cataract, anterior segment examination was unremarkable. Funduscopy and fl uorescein angiography revealed a left-sided optic nerve head edema (Figure 2 ), corresponding to superior altitudinal fi eld defect and generalized depression.
Erythrocyte sedimentation rate was 17mm (1st hour). C-reactive protein was found within normal range. On initial work-up, hematocrit was 30.7%, white blood cell count 4.3 × 10 9 /lt and platelets 307 × 10 9 /lt. Blood pressure was 130/70 mmHg and remained within normal range throughout hospitalization. Dosage adjustment of his erythropoietin infusion rather than transfusion of packed red cells was preferred by the hematologist.
Within one week, visual acuity slightly improved to 20/200 OS and remained stable for the rest of the follow-up period (6 months). The visual fi elds remained severely constricted and atrophy of the left optic disc was noted.
Discussion
Hypertension, diabetes mellitus, and nocturnal hypotension have all been associated with the initiation of non-arteritic anterior ischemic optic neuropathy, 1 with a congenitally anomalous optic disc with a small optic cup being an additional important risk factor. 5 Acute anemia and hypotension are also known to be linked with shock-induced ischemic optic neuropathy in the course or immediately after massive gastrointenstinal hemorrhage and major surgical procedures. 6, 7 Although neuronal tissue generally meets its oxygen requirement even with profound anemia, there is evidence that the presence of an additional factor may induce neuronal tissue dysfunction. Chronic anemic patients with carotid stenosis, for example, have demonstrated transient neurological defi cits during intermittent reductions of hemoglobin below a critical level. 8 Similarly, children with generally well-tolerated iron defi ciency anemia have presented with an ischemic stroke when a metabolic stress could not be met. 9 Moreover chronic anemia due to repeated gastrointestinal bleeding has been reported to cause bilateral optic nerve infarction in the presence of acute hypotension.
The refractory anemia subtype of MDS, is likely to be involved in the initiation of NAION through a mechanism of anemic hypoxia and/or microvascular insuffi ciency. Our fi rst case, an otherwise healthy man, presented with hypotension (maximum blood pressure 90/65 mmHg), whereas the second patient reported a history of hypothyroidism and chronic renal failure, which may induce episodes of hypotension, especially following hemodialysis sessions. The association of NAION with hypotension in the setting of renal failure and hemodialysis was fi rst reported by Servilla and Groggel in 1986, 11 whereas Haider et al detected four cases of NAION after a 24-month follow-up of 60 patients under dialysis and implicated hypotension in one case, severe anemia in another one and generalized atherosclerosis in two patients. 12 Although, theoretically, hypotension alone could trigger the manifestation of NAION in cases 1 and 2, our third patient -otherwise hematologically stable -developed optic neuropathy during a febrile respiratory infection that involved oxygen saturation changes.
The course of nonarteritic anterior ischemic optic neuropathy varies considerably. In most patients there is no further loss of vision although, in a small percentage, visual loss continues for several weeks. On the other hand, the Ischemic Optic Neuropathy Decompression Trial Research Group reports spontaneous improvement of visual acuity in 23.8% of patients and of visual fi elds in a further 24%, comprising as many as 42.7% of NAION cases. 13, 14 In this context, the contribution of vigorous transfusion in the observed relative recovery of visual function of the two patients cannot be determined.
An alternative approach to the disease process would implicate a mechanism of vasculitis of the short posterior ciliary arteries. Small vessel vasculitis, of unclear pathogenesis so far, reportedly complicates approximately 10% of MDS and presents as cutaneous vasculitis and lupus-like syndromes. 15, 16 Our patients, however, did not report previous vasculitic manifestations and their erythrocyte sedimentation rate and C-reactive protein were normal.
This case series implies that the chronic anemia of myelodysplastic syndrome's refractory anemia subtype may be associated with the development of non-arteritic anterior ischemic optic neuropathy, presumably in the presence of an additional factor, such as hypotension, chronic renal failure, or metabolic disorder. Further research aiming to determining the odds ratio of developing NAION in association with refractory anemia MDS would place this link in perspective and justify the monitoring of these patients for a major opththalmic complication.
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